Immunopathogenic mechanisms of systemic autoimmune disease
- PMID: 23993191
- DOI: 10.1016/S0140-6736(13)60954-X
Immunopathogenic mechanisms of systemic autoimmune disease
Abstract
Systemic lupus erythematosus, Sjögren's syndrome, and dermatomyositis are systemic autoimmune diseases that develop after environmental triggering of genetically susceptible individuals. The precise cellular and molecular mechanisms leading to autoimmune disease, and what factors determine which organs are involved, remain poorly understood. Recent insights into genetic susceptibility now make obvious that environmental triggers often act via cellular pathways containing disease-associated polymorphisms. In the breaking of tolerance, the initiating tissue--including dendritic cells--provides a decisive microenvironment that affects immune-cell differentiation, leading to activation of adaptive immunity. Type 1 interferon produced by innate immune cells has a central role in systemic autoimmunity and activates B cells and T cells. In turn, B-cell-derived autoantibodies stimulate dendritic cells to produce type 1 interferon; thus, a positive feedforward loop is formed that includes both the innate and adaptive systems. New treatments could simultaneously and specifically target several such vital pathways in autoimmunity.
Copyright © 2013 Elsevier Ltd. All rights reserved.
Similar articles
-
Diseases of autoimmunity.Natl Cancer Inst Monogr. 1982;60:181-92. Natl Cancer Inst Monogr. 1982. PMID: 6214718 No abstract available.
-
B cell biology: implications for treatment of systemic lupus erythematosus.Lupus. 2013 Apr;22(4):342-9. doi: 10.1177/0961203312471576. Lupus. 2013. PMID: 23553777 Review.
-
Myasthenia Gravis: paradox versus paradigm in autoimmunity.J Autoimmun. 2014 Aug;52:1-28. doi: 10.1016/j.jaut.2014.05.001. Epub 2014 Jun 13. J Autoimmun. 2014. PMID: 24934596 Review.
-
Genetic associations in type I interferon related pathways with autoimmunity.Arthritis Res Ther. 2010;12 Suppl 1(Suppl 1):S2. doi: 10.1186/ar2883. Epub 2010 Apr 14. Arthritis Res Ther. 2010. PMID: 20392289 Free PMC article. Review.
-
[The immune system and inflammatory diseases].Ugeskr Laeger. 2008 Jun 9;170(24):2110-5. Ugeskr Laeger. 2008. PMID: 18565290 Review. Danish.
Cited by
-
Transcriptional profiling upon T cell stimulation reveals down-regulation of inflammatory pathways in T and B cells in SLE versus Sjögren's syndrome.NPJ Syst Biol Appl. 2023 Dec 15;9(1):62. doi: 10.1038/s41540-023-00319-z. NPJ Syst Biol Appl. 2023. PMID: 38102122 Free PMC article.
-
Systemic lupus erythematosus does not prevent antibody responses to SARS-CoV-2.Lancet Rheumatol. 2021 Aug;3(8):e538-e540. doi: 10.1016/S2665-9913(21)00153-3. Epub 2021 May 27. Lancet Rheumatol. 2021. PMID: 34075357 Free PMC article. No abstract available.
-
A Narrative Literature Review Comparing the Key Features of Musculoskeletal Involvement in Rheumatoid Arthritis and Systemic Lupus Erythematosus.Rheumatol Ther. 2022 Jun;9(3):781-802. doi: 10.1007/s40744-022-00442-z. Epub 2022 Mar 31. Rheumatol Ther. 2022. PMID: 35359260 Free PMC article. Review.
-
Efficacy and safety of baricitinib in treatment of systemic lupus erythematosus: a systematic review and meta-analysis.BMC Rheumatol. 2023 Oct 31;7(1):40. doi: 10.1186/s41927-023-00363-6. BMC Rheumatol. 2023. PMID: 37904221 Free PMC article.
-
The rheumatic disease-associated FAM167A-BLK locus encodes DIORA-1, a novel disordered protein expressed highly in bronchial epithelium and alveolar macrophages.Clin Exp Immunol. 2018 Aug;193(2):167-177. doi: 10.1111/cei.13138. Epub 2018 May 16. Clin Exp Immunol. 2018. PMID: 29663334 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical